SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte ...

David Zaccardelli, Pharm.D. joins Board as ChairRita Jain, M.D., joins Board as an Independent DirectorMIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ...

As of Monday, January 05, SAB Biotherapeutics, Inc.’s SABS share price has dipped by 5.57%, which has investors questioning ...

SAB BIO has announced a $175 million private placement financing to fund its pivotal Phase 2b SAFEGUARD study of SAB-142, aimed at delaying the progression of autoimmune type 1 diabetes (T1D) in newly ...

The Staff Accounting Bulletin (SAB) 121 rule was introduced by the SEC in March 2022 as part of its efforts to regulate cryptocurrency custody. It required financial institutions to list any crypto ...

SAB Biotherapeutics ( ($SABS) ) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with ...

Forbes contributors publish independent expert analyses and insights. Shaping the future of banking with bitcoin. (Full disclosure: I’m helping build Coinbits.app, a bitcoin banking platform.) In a ...

MIAMI, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...

Issued on March 31, 2022, SAB 121 required public companies holding crypto on behalf of their customers to record customer-held crypto assets on their balance sheets as both an asset and a ...

SAB has launched a new, more modern logo. Its CEO believes better times lie ahead for South Africa thanks to a growing youthful population. A merged Heineken and Distell group could bring more ...